JW (Cayman) Therapeutics Co. Ltd (HKG:2126)
Hong Kong
· Delayed Price · Currency is HKD 1.870
-0.030 (-1.58%)
Jun 4, 2025, 4:08 PM HKT
HKG:2126 Market Cap
HKG:2126 has a market cap or net worth of 758.03 million as of June 4, 2025. Its market cap has increased by 0.40% in one year.
Market Cap
758.03M
Enterprise Value
396.07M
Revenue
168.37M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.87
Market Cap Chart
Since November 3, 2020, HKG:2126's market cap has decreased from 8.28B to 758.03M, a decrease of -90.84%. That is a compound annual growth rate of -40.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 4, 2025 | 758.03M | 46.33% |
| Dec 31, 2024 | 518.01M | -42.89% |
| Dec 29, 2023 | 907.01M | -47.90% |
| Dec 30, 2022 | 1.74B | -67.36% |
| Dec 31, 2021 | 5.33B | -47.83% |
| Dec 31, 2020 | 10.22B | 23.51% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 228.28B |
| Hansoh Pharmaceutical Group Company | 154.59B |
| JD Health International | 127.36B |
| Innovent Biologics | 104.09B |
| WuXi Biologics | 101.51B |
| CSPC Pharmaceutical Group | 88.12B |
| Sino Biopharmaceutical | 78.73B |
| Alibaba Health Information Technology | 72.53B |